---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-230240"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2024-10-01T23:59:59+00:00"
generated_at: "2026-05-30T23:28:40.533598+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Verrica cuts 47 jobs, expects $1.0M restructuring charge

## Summary
- Workforce reduction of 47 employees, substantially completed by October 1, 2024.
- Total restructuring expense estimated at $1.0M: $0.7M termination costs and $0.3M vehicle sale loss.
- Charge to be recorded in Q4 2024; cash payments expected by November 30, 2024.
- Board approved September 23, 2024 to streamline operations and preserve capital.
- One-time costs are the only direct expenses of the restructuring plan.

## SEC filing metadata
- accession: 0001193125-24-230240
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2024-10-01T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312524230240/0001193125-24-230240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312524230240/d823075d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-230240
- JSON: https://secwatch.observer/filing/0001193125-24-230240.json
- Plain text: https://secwatch.observer/filing/0001193125-24-230240.txt

## Key facts
- Restructurings & Charges
  Verrica Pharmaceuticals Inc. announced a restructuring with charges of approximately $1.0 million, including a one-time charge totaling approximately $0.7 million in connection with one-time employee termination costs, including se (reduction of its workforce by 47 employees).
  - Type: restructuring
  - Charge: approximately $1.0 million, including a one-time charge totaling approximately $0.7 million in connection with one-time employee termination costs, including se
  - Headcount: reduction of its workforce by 47 employees
  source text: On October 1, 2024, Verrica Pharmaceuticals Inc. (the “Company”) announced a reduction of its workforce by 47 employees, which the Company expects to be substantially completed by October 1, 2024. The Board of Directors of the Company approved these actions on September 23, 2024 in order to streamline operations, reduce costs, and preserve capital. As a result, the Company expects to incur total expenses of approximately $1.0 million, including a one-time charge totaling approximately $0.7 million in connection with one-time employee termination costs, including severance and other benefits, and an estimated deemed loss on vehicle sales of $0.3 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1660334/000119312524230240/0001193125-24-230240-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.